Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Peter Singleton who wrote (4943)	7/22/1998 10:37:00 AM
From: John Metcalf	Read Replies (2) \| Respond to of 6136

Thanks for the conf call report, Peter. Just one question.... Didn't they say "publically traded" tracking stock? In that case, they keep a majority of the shares and raise new money for oncology product development. That would not be dilutive to shareholders. A number of contributors to this thread have wished for more information on the cancer program, and a separate company subsidiary would focus on just that. And those who want to follow just the HIV franchise can do so. I am hoping that they will do something to leverage the salesforce. A marketing arrangement for another HIV product would be excellent.